コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 transplantation in a mouse genetic model of autism.
2 oral abnormalities that bear similarities to autism.
3 sociated with clinical phenotypes of FXS and autism.
4 depression, 3 of 11 for ADHD and 1 of 2 for autism.
5 es of excitation and inhibition imbalance in autism.
6 approach to overcoming the heterogeneity of autism.
7 ized to contribute to the pathophysiology of autism.
8 oup of patients with dyslipidemia-associated autism.
9 early prenatal development may be altered in autism.
10 e its over-expression increases the risk for autism.
11 ould be a potential therapeutic strategy for autism.
12 rologic disorders, such as schizophrenia and autism.
13 for targeted intervention of FXS and perhaps autism.
14 ed cellular events during prenatal stages in autism.
15 elevated prenatal steroidogenic activity in autism.
16 opmental disorders such as schizophrenia and autism.
17 py for neuropsychiatric disorders, including autism.
18 eterogeneous groups that are not specific to autism.
19 ently test early-developmental hypotheses of autism.
20 identified in up to 20% of individuals with autism.
21 ing them to diseases such as Alzheimer's and autism.
22 rdation and the primary monogenetic cause of autism.
23 understand movement imitation differences in autism.
24 between prenatal antidepressant exposure and autism.
25 al role in defining the clinical features of autism.
26 oping treatments for AS and various forms of autism.
27 ion of prenatal antidepressant exposure with autism.
28 LGN4 and can lead to synaptic dysfunction in autism.
29 ine personality disorder, schizophrenia, and autism.
30 epresentational impairment in autism, making autism a natural behavioural and neurophysiological test
31 in patients with intellectual disability and autism ablate its catalytic activity or ankyrin-G intera
35 ging variants in genes associated with human autism and developmental delay, providing a framework fo
37 enabling role of tau in the pathogenesis of autism and identify tau reduction as a potential therape
38 er of genes enriched for syndromic causes of autism and intellectual disability and for genes that in
39 anagement of neurological disorders, such as autism and intellectual disability, that are characteriz
41 tion phenotype increases in populations with autism and is associated with weaker cognitive abilities
44 nucleotide variants that are associated with autism and schizophrenia are colocalized with distinct c
45 omolog of the human CYFIP1, a gene linked to autism and schizophrenia, exhibit mitochondrial hyperact
51 opmental and psychiatric diagnoses including autism, and measures of traits related to autism (self-r
56 ormation is not chronically underweighted in autism, as proposed by simple Bayesian accounts of the d
57 well as 67 adult individuals diagnosed with autism (ASD), schizophrenia (SZ), and Down syndrome (DS)
63 ealthy control data from the ABIDE I and II (Autism Brain Imaging Data Exchange) and PING (Pediatric
67 odular, machine learning-based assessment of autism comprising three complementary modules for a unif
68 hat have not been previously reported in any autism database: CHM, ENPP1, IGF1, LAS1L, SYP and TBX22.
71 ulation-level dataset, we find that rates of autism diagnosis continued to be on the rise in recent y
73 Since oxytocin reduced the primary endpoint, Autism Diagnostic Observation Schedule (ADOS) reciprocit
75 transitions, the functional implications of autism disease mutations and the role of phosphoinositid
77 that infants who go on to be diagnosed with autism exhibit early differences in gaze behaviour that
80 stimuli in infants at high and low risk for autism from the British Autism Sibling Infant Study (BAS
81 illustrate how the loss of a high confidence autism gene can impair long-range communication by causi
85 the protein tau prevents behavioral signs of autism in two mouse models simulating distinct causes of
88 rmal sensory processing has been observed in autism, including superior visual motion discrimination,
90 et of high-risk infants later diagnosed with autism, infant theta EEG explained over 80% of the varia
99 hypothesis regarding the pathophysiology of autism is that an increase in the balance between neural
100 Maternal immune activation (MIA) induces autism-like behaviors in offspring, but how it interplay
101 tionally performed in a gene associated with autism-like symptoms and epileptic seizures for further
102 associated with severe mental disability and autism-like symptoms that affect girls during early chil
103 e one of core synaptic mechanisms underlying autism-like synaptic dysfunction and social behavioral a
104 show that prenatal oestrogens contribute to autism likelihood, extending the finding of elevated pre
108 hierarchy of representational impairment in autism, making autism a natural behavioural and neurophy
109 a neural deficit in prediction, people with autism manifest low perceptual construal and are impaire
110 ue developmental differences associated with autism may be established at early prenatal stages.
111 phenotypes in autism models, suggesting that autism may be treated by correcting underlying deficits
112 the second, we show how the heterogeneity of autism mechanisms in humans can be broken down by functi
113 ntion-deficit/hyperactivity disorder (ADHD), autism, mild facial dysmorphism, craniosynostosis, and m
114 iated with improved behavioral phenotypes in autism models, suggesting that autism may be treated by
116 In stark contrast, the risk for developing autism or developmental delay does not significantly cha
117 ense variant STB-R178Q, which is found in an autism patient and loses its adapter capacity for bindin
119 re features of ASD, referred to as the broad autism phenotype (BAP), have been documented repeatedly
120 iated decay (NMD) of splicing isoforms, with autism phenotypes usually triggered by relatively mild (
121 idence that prioritized de novo mutations in autism probands point to a small set of well-known ASD g
123 diminished synaptic density and reduction of autism-related PSD-95 and Homer-1 in the hippocampus, wh
124 e data suggest that 16p11.2 DEL mice show an autism-relevant phenotype that becomes overt after an ac
126 ficantly enriched for ASD (Simons Foundation Autism Research Initiative), synaptic, and cell cycle ge
127 ude between adjacent stages of processing in autism: responses are attenuated in a primary visual are
133 identifies a convergence between the genetic autism risk factor Nlgn3, regulation of translation, and
134 two functional de novo variants in a pRE for autism risk gene SLC6A1, and using CRISPRa, demonstrated
138 osome make the largest known contribution to autism risk, and correlate with paternal age at the time
139 ted by insular cortex dysfunction, including autism, schizophrenia, and fronto-temporal dementia.
141 ng autism, and measures of traits related to autism (self-report measures of autistic traits, empathy
142 matter development between individuals whose autism severity increased, remained stable, or decreased
143 ratum, autistic individuals who increased in autism severity over time had a slower developmental tra
146 ortical neurons were RNA-sequenced to reveal autism-specific signatures similar to postmortem brain s
147 ns of recent efforts to identify relatively "autism-specific" genes, efforts which focus on rare vari
148 with four major neuropsychiatric disorders: autism spectrum condition (ASC), bipolar disorder (BD),
149 development and behavior in 96 children with autism spectrum disorder (ASD) [45 with neurodevelopment
150 s investigated neuroradiological findings in autism spectrum disorder (ASD) and attention-deficit hyp
151 isorders and neurogenetic syndromes, such as autism spectrum disorder (ASD) and Dravet, Fragile X, Pr
154 been noted consistently in individuals with autism spectrum disorder (ASD) and their families, inclu
155 riched for genes implicated in non-syndromic autism spectrum disorder (ASD) and were differentially e
157 al motion (BM) and its putative anomalies in autism spectrum disorder (ASD) are not completely clarif
158 s of sociality in individuals diagnosed with autism spectrum disorder (ASD) are standardly explained
160 n in neural suppression in young adults with autism spectrum disorder (ASD) compared to neurotypical
162 ASD.SIGNIFICANCE STATEMENT Individuals with autism spectrum disorder (ASD) exhibit atypical attentio
163 e hypothesized link between gut bacteria and autism spectrum disorder (ASD) has been explored through
166 r ex vivo histological postmortem studies of autism spectrum disorder (ASD) have shown gray matter mi
181 nditions with etiological heterogeneity like Autism Spectrum Disorder (ASD) often pose a challenge fo
184 aracterize their diagnoses, individuals with autism spectrum disorder (ASD) show enhanced performance
185 resent the largest exome sequencing study of autism spectrum disorder (ASD) to date (n = 35,584 total
186 esents particular challenges for youths with autism spectrum disorder (ASD) who often struggle to beh
187 tations in PTEN account for ~10% of cases of autism spectrum disorder (ASD) with coincident macroceph
188 ability, is the leading monogenetic cause of autism spectrum disorder (ASD), a neurodevelopmental con
190 b are associated with X-linked macrocephaly, autism spectrum disorder (ASD), and intellectual disabil
191 key phenotypes in individuals diagnosed with autism spectrum disorder (ASD), and may potentially cont
192 ntion deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and obsessive-compulsive
193 s frequently disrupted in male subjects with autism spectrum disorder (ASD), but the functional conse
194 ifferent neuropsychiatric diseases including Autism Spectrum Disorder (ASD), intellectual disabilitie
195 oduplications of 16p11.2 are associated with autism spectrum disorder (ASD), intellectual disability
197 he effects of oxytocin on social deficits in autism spectrum disorder (ASD), no large-scale study has
199 SIB) is among the most dangerous concerns in autism spectrum disorder (ASD), often requiring detailed
200 Number Variants (CNVs) confer high risk for Autism Spectrum Disorder (ASD), schizophrenia (SZ), and
219 renia (N = 696), bipolar disorder (N = 211), autism spectrum disorder (N = 126), or major depressive
220 unced for childhood-onset disorders, such as autism spectrum disorder and attention-deficit/hyperacti
221 from two related neuropsychiatric disorders-autism spectrum disorder and bipolar disorder-to show th
222 nalysis of de novo variants in patients with autism spectrum disorder and intellectual disability or
223 re repeatedly identified as risk factors for autism spectrum disorder and intellectual disability, bu
224 enuated by missense variants associated with autism spectrum disorder and intellectual disability.
225 tent of brain tissue in Alzheimer's disease, autism spectrum disorder and multiple sclerosis is signi
232 2-week clinical phase 2 study in adults with autism spectrum disorder balovaptan demonstrated improve
233 surrogates of social behavior in adults with autism spectrum disorder in an exploratory proof-of-mech
234 lted in a behavioral phenotype suggestive of autism spectrum disorder in the xCT(-/-) mice; in tests
237 nd that schizophrenia, bipolar disorder, and autism spectrum disorder share similar white matter micr
238 pplication to heterogenous disorders such as autism spectrum disorder will require individual-subject
241 risk factor for global developmental delay, autism spectrum disorder, and epileptic encephalopathy.
242 risk factor for global developmental delay, autism spectrum disorder, and epileptic encephalopathy.
243 intellectual disability/developmental delay, autism spectrum disorder, and multiple medical comorbidi
245 athology of psychiatric disorders, including autism spectrum disorder, bipolar disorder, major depres
246 ntion deficit hyperactivity disorder (ADHD), autism spectrum disorder, bipolar disorder, major depres
247 e of neurodevelopmental disorders, including autism spectrum disorder, intellectual disability, and e
248 or depressive disorder, depressive symptoms, autism spectrum disorder, psychosis, and alcohol use dis
249 ric, and neurodegenerative disorders such as autism spectrum disorder, schizophrenia, and Huntington'
261 antibodies contributes to the development of autism spectrum disorders (ASD) has been entertained for
264 adsorption, is one of the possible causes of autism spectrum disorders (ASD) predominantly in patient
266 and debilitating symptom in individuals with autism spectrum disorders (ASD), but the neural basis un
268 uli were presented to adult individuals with autism spectrum disorders (ASD; n = 24, mean age 23 year
269 Taok2-dependent ASDs.SIGNIFICANCE STATEMENT Autism spectrum disorders (ASDs) are linked to abnormal
271 elopmental defects.SIGNIFICANCE STATEMENT In autism spectrum disorders (ASDs), prenatal infection or
272 ebellar dysfunction has been demonstrated in autism spectrum disorders (ASDs); however, the circuits
273 tions in Shank3 are strongly associated with autism spectrum disorders and neural circuit changes in
275 ental challenge in developing treatments for autism spectrum disorders is the heterogeneity of the co
280 Furthermore, the genetic interaction with autism-spectrum genes, such as ASH1L, DYRK1A, MED13, and
281 ts were selected based on their score on the Autism-Spectrum Quotient (AQ), and AQ scores were assess
284 osome 16p11.2 dramatically increase risk for autism, suggesting that mice with an equivalent genetic
286 When CNV effects on IQ are accounted for, autism susceptibility remains mostly unchanged for dupli
287 culus, autistic individuals who decreased in autism symptom severity also had greater increases in fr
288 tion to diagnosis, developmental stage, core autism symptomatology, and associated psychiatric sympto
290 MEF2C gene are linked to a syndromic form of autism termed MEF2C haploinsufficiency syndrome (MCHS).
292 the major source of support for people with autism throughout much of life and need to be considered
294 res and performance in our task, but do find autism trait related differences in learning rate parame
295 ith neurodevelopmental disability, including autism traits, inattention and hyperactivity, and ataxia
296 n could offer a novel cell-based approach to autism treatment while challenging assumptions that effe
298 f SHANK3 causes Phelan-McDermid syndrome and autism, whereas duplication of the same gene leads to SH
299 eveal a possible relationship between AD and autism, which are linked to the same environmental facto
300 generated from 9 unrelated individuals with autism without macrocephaly and with heterogeneous genet